ASPG and neoplasm: It has been shown that combined L-asparaginase and general control non-derepressible 2 (GCN2) inhibitor GCN2iA/B or MEK inhibitor PD-325901 could enhance the inhibition of pancreatic cell proliferation and tumor growth (142, 143).